Pfizer — Seoul

Public research footprint of Pfizer, compiled from the ClinicalTrials.gov public registry.

117

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

COVID-19 · Arthritis, Rheumatoid · SARS-CoV-2 · Safety

Recently updated registry entries

NCT05131100 — Korean Regulatory Post Marketing Surveillance for Somavert (Completed)
NCT04876781 — Korean Post-marketing Surveillance for Xeljanz XR (Recruiting)
NCT06743334 — Secondary Databased Post-marketing Surveillance Study of BNT162b2 (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Pfizer?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.